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Abstract
Background: Precise blood pressure (BP) measurements are central for the diagnosis of hypertension in clinical and
epidemiological studies. The purpose of this study was to quantify the variability in BP associated with arm side, body
position, and successive measurements in the setting of a population-based observational study. Additionally, we aimed
to evaluate the influence of different measurement conditions on prevalence of hypertension.
Methods: The sample included 967 men and 812 women aged 45 to 83 years at baseline. BP was measured according
to a standardized protocol with oscillometric devices including three sitting measurements at left arm, one simultaneous
supine measurement at both arms, and four supine measurements at the arm with the higher BP. Hypertension was
defined as systolic BP (SBP) ≥140mmHg and/or diastolic BP (DBP) ≥90mmHg. Variability in SBP and DBP were analysed
with sex-stratified linear covariance pattern models.
Results: We found that overall, no mean BP differences were measured according to arm-side, but substantial higher
DBP and for men also higher SBP was observed in sitting than in supine position and there was a clear BP decline by
consecutive measurement. Accordingly, the prevalence of hypertension depends strongly on the number and scheme
of BP measurements taken to calculate the index values.
Conclusions: Thus, BP measurements should only be compared between studies applying equal measurement
conditions and index calculation. Moreover, the first BP measurement should not be used to define hypertension since
it overestimates BP. The mean of second and third measurement offers the advantage of better reproducibility over
single measurements.
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Background
The indirect blood pressure (BP) measurement by a
trained observer is widely used in clinical and epidemio-
logical practice as accurate BP measurement. Office BP
has shown a good validity when compared with 24-h
ambulatory BP measurements (correlation of 0.9 and 0.8
for systolic BP and diastolic BP respectively) [1]. Precise
BP measurements are central for the diagnosis of hyper-
tension and for clinical or epidemiological studies where
blood pressure is used as exposure or outcome of interest.
Several factors affect BP measurement, such as
environmental factors (i.e. temperature, noise); factors
related to the participant (i.e. vigorous physical activity,
heavy meal or smoking before measurement); factors
related to the device (i.e. cuff size, calibration error) or
to the measurement procedure (i.e. left vs. right arm,
supine vs. sitting) [2–7]. According to Tolonen et al.
[8], these result in variations from 1–2 mmHg up to
20–50 mmHg in individual measurements.
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Inter-arm differences in BP vary with the population
studied. Some previous studies have suggested a bias
towards higher readings from the right arm [9–11],
whereas others have failed to show this [12–15]. Addition-
ally, disagreement exists as to whether body position
would make any difference in BP readings [6, 16–18].
Several studies have shown that mean supine systolic BP
(SBP) is 2–3 mmHg higher and diastolic BP (DBP)
3–5 mmHg lower than sitting BP [6, 16, 17]. However,
other studies suggest that posture is unlikely to have signifi-
cant impact on BP readings [18, 19]. Further, little is known
about the magnitude of differences between consecutive BP
readings in epidemiologic studies. The results of these
studies are conflicting regarding the arm-side, body
position and reading order in measured BP (successive
measurements in and of itself). Moreover, not only
additional unmeasured conditions, but also, already known
participants characteristics could further contribute to these
inconsistencies. For example, the well-known sex-specific
differences in onset and rate of hypertension [20]. Thus an
epidemiological study with a highly standardised study
protocol, from a sex and age-stratified random sample,
measurements conducted by a single trained qualified study
nurse and a single weekly checked device could provide
helpful information in explaining these uncertainties.
Considering the important clinical and epidemiological im-
plications from these differences; i.e., variations in measured
BP could lead to variable diagnosis and bias in BP estimates
and hypertension frequencies from epidemiological studies,
it is important to determine the estimated effect of each of
these conditions on the measured BP.
The purpose of this study was therefore, to quantify the
variability in BP associated with: a) arm side: right vs left;
b) body position: sitting vs supine and c) successive mea-
surements: 1 to 8; in the setting of a population based ob-
servational study. Additionally, we aimed to evaluate the
influence of different measurement conditions on preva-
lence of hypertension (defined as SBP above or equal 140
and/or DBP above or equal 90 mmHg).
Methods
Participants and setting
The CARLA-Study is a population based cohort study in
an elderly population of the city of Halle (Saale) in eastern
Germany. Study design and methods were described in
detail elsewhere [21]. In brief, subjects were recruited as a
random and representative sample from the population
registry in a multi-stage process. At baseline 1779 subjects
(46% women) aged 45 to 83 years were examined between
July 2002 and January 2006 (response rate 64%). The study
was in accordance with the declaration of Helsinki. All
participants gave their written informed consent. The study
was approved by the local ethic commission at the Medical
Faculty of the Martin-Luther-University Halle-Wittenberg.
Outcome
Measurement of BP was conducted within the medical
examination after a resting phase of at least five minutes.
Systolic and diastolic BP were measured in a sitting
position with an oscillometric device (OMRON HEM-
705CP, OMRON, Tokyo, Japan) three times on the left
arm with a break of three minutes between measure-
ments, one simultaneous supine measurement at both
arms, and four supine measurements at the arm with the
higher BP (see flow chart, Additional file 1: Figure S1).
Hypertension was within CARLA defined as mean
systolic BP (SBP) equal or above 140 mmHg, and/or mean
diastolic BP (DBP) above 90 mmHg (defined as the mean
of second and third measurement) following [22].
Statistical analysis
Bland-Altman plots were used to graphically illustrate
the variability for the 8 BP measurements. BP values
between measurements were evaluated by sex-stratified
linear covariance pattern models [23]. The following var-
iables were entered into all of the models as fixed effects
(confounders): arm-position (left-sitting, left-supine,
right-supine), measurement (1 to 8), and their inter-
action. A residual ARMA (1,1) (autoregressive moving-
average) process was included to account for the
additional correlation of BP measurements in the time
course within the same participant. All analyses were
performed with SAS® 9.3 (SAS Inc., Cary, NC, USA).
Results
A total of 1779 participants (46% women) took part in
the baseline examinations, comparisons could be done
among 1743 participants (45% women) with measure-
ments in left and right arm; 1728 (46% women) with
measurements in sitting and supine positions and 1778
(46% women) participants with first to third sitting mea-
surements (Table 1). One participant refused to have any
BP measurements. Further 36 participants had no supine
BP measurements due to contraindication (i.e. throm-
bose, amputation) or declined participation and for fur-
ther 15 participants the supine BP measurements had to
be stopped before completion.
Figure 1 shows that there were no large mean differ-
ences in the BP measurements in left vs right arm. Mean
differences were for SBP 0.05 mmHg (95% CI (confi-
dence interval) = -0.27 to 0.38) and for DBP −0.98 mmHg
(95% CI = -1.19 to−0.77). Though, approximately 10% of
the participants had differences greater than 10 mmHg
for SBP and about 15% had differences greater than
5 mmHg for DBP. These differences of 10 mmHg for
SBP and 5 mmHg for DBP have been previously shown
to be clinically relevant [24].
A further analysis involved the order of the BP
measurement (successive measurements): first vs second
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Table 1 Baseline characteristics of the CARLA study population (2002–2006): distribution of cardiovascular risk factors and diseases
Women Men
N Median Min; Q1; Q3; Max N Median Min; Q1; Q3; Max
Age (years) 812 63.3 45.8; 54.9; 71.8; 83.4 967 64.9 45.4; 55.8; 74.0; 83.3
SBP (mmHg) 812 138.0 89.0; 125.5; 155.0; 231.0 966 145.5 93.0; 131.5; 158.5; 227.0
DBP (mmHg) 812 82.5 54.0; 76.0; 90.0; 122.0 966 85.5 52.5; 78.5; 93.0; 127.0
Heart rate (1/min) 778 67.0 39.4; 60.9; 73.4; 105.4 893 65.7 43.9; 60.2; 74.7; 112.4
Total cholesterol (mmol/l) 807 5.7 1.4; 5.0; 6.4; 10.7 960 5.3 2.1; 4.9;5.9; 17.8
HDL cholesterol (mmol/l) 807 1.5 0.4; 1.3; 1.8; 3.4 960 1.2 0.3; 1.0;1.5; 3.0
LDL cholesterol (mmol/l) 801 3.4 0.9; 2.8; 4.0; 7.3 940 3.1 0.9; 2.6;3.7; 7.2
Cholesterol/HDL ratio 807 3.8 1.7; 3.0; 4.5; 9.7 960 4.3 1.7; 3.5; 5.2; 13.0
Triglycerides (mmol/l) 807 1.4 0.2; 1.0; 1.9; 11.6 960 1.7 0.4; 1.2;2.5; 38.2
Glucose (mmol/l) 807 5.4 3.1; 5.1; 5.9; 19.8 960 5.6 3.0; 5.2;6.3; 21.5
HbA1c (%) 807 5.6 3.1; 5.3;5.9; 12.0 960 5.6 2.8; 5.3;6.0; 11.7
Body mass index (kg/m2) 812 28.0 18.1; 24.7; 31.5; 53.7 967 27.7 16.5; 25.4;30.8; 43.3
Waist hip ratio 812 0.9 0.7; 0.8; 0.9; 1.2 967 1.0 0.8; 1.0; 1.0; 1.2
For current smokers: pack-years 119 19.5 0.2; 10.6; 26.6; 61.0 225 29.0 0.5; 18.0; 38.4; 85.1
Alcohol consumption gram/day 812 0 0; 0; 5.0; 60.5 964 12.5 0; 2.5; 26.2; 113.6
N Proportion 95% CI N Proportion 95% CI
Smoking 812 966
Current 119 14.7 12.2–17.1 225 23.3 20.6–26.0
Past 140 17.2 14.6–19.8 496 51.3 48.2–54.5
Never 553 68.1 64.9–71.3 245 25.4 22.6–28.1
Sports: physically active 347 42.8 39.4–46.2 296 30.6 27.7–33.6
Education yearsa 812 967
≤10 121 14.9 12.4–17.4 36 3.7 2.5–4.9
11–13 388 47.8 44.3–51.2 391 40.4 37.3–43.5
14–17 231 28.4 25.3–31.6 335 34.6 31.6–37.6
≥18 72 8.9 6.9–10.8 205 21.2 18.6–23.8
Drug use
Beta-blockers 279 34.4 31.1–37.6 307 31.7 28.8–34.7
Anti-arrhythmics 5 0.6 0.1–1.2 8 0.8 0.3–1.4
ACE-inhibitors 254 31.3 28.1–34.5 340 35.2 32.1–38.2
Diuretics 80 9.9 7.8–11.9 104 10.8 8.8–12.7
Ca-channel blockers 123 15.1 12.7–17.6 148 15.3 13.0–17.6
Disease prevalence
Myocardial infarction 20 2.4 0.8–3.7 50 5.2 2.7–7.6
Stroke 27 3.3 2.1–4.6 42 4.3 3.1–5.6
Cardiovascular diseaseb 48 5.9 4.3–7.5 153 15.8 13.5–18.1
Hypertensionc 611 75.2 72.3–78.2 794 82.1 79.7–84.5
Diabetes mellitusd 120 14.8 12.3–17.2 154 15.9 13.6–18.3
SBP systolic blood pressure, DBP diastolic blood pressure, HDL high density lipoprotein cholesterol, LDL low density lipoprotein cholesterol, HbA1c glycated
hemoglobin, ACE angiotensin converting enzyme, Ca-channel blockers calcium-channel blockers
aEducation (years of training) according to ISCED classification 1997
bCVD: including prevalent myocardial infarction, coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA), stroke,
carotid surgery
cHypertension defined as SBP equal or above 140 and/or DBP equal or above 90 mmHg, and/or use of antihypertensive medication
dDiabetes defined as self-reported physician-diagnosed diabetes mellitus and/or use of anti-diabetic medication
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in sitting (Figure 2). Participants had in average
1.64 mmHg greater SBP (95% CI = 1.20 to 2.08) and
0.51 mmHg greater DBP (95% CI = 0.27 to 0.74) in the
first sitting measurement. About 20% of the study partici-
pants had differences greater than 10 mmHg for SBP and
also 20% had differences greater than 5 mmHg for DBP.
Figure 3 shows the adjusted means with 95% CI for
differences in BP in consecutive measurements for men
and women respectively. For SBP there are clear differ-
ences in sitting position for men and women between
first and second and slightly less between second and
third measurements, with up to mean differences of
2 mmHg for women between first and second measures.
Very similar patterns could be seen for SBP measure-
ments in supine position, with greater differences for
women than for men and decreasing in size with further
measurements. For DBP, there are also clear differences
in sitting position for men and women between first and
second and less between second and third measure-
ments, with up to almost 1 mmHg in average for women
between first and second measures. However, differences
between right and left arm DBP measurements were
higher for men, with differences above 1 mmHg. DBP
measurements in supine position showed similar pat-
terns for men and women, such that there is a decrease
in size with further measurements. The only significant
a
b
Fig. 1 BP arm differences in measurement 4 (supine left and right arm simultaneously). BP differences between right and left arm (right – left)
over mean of BP right and left arm for a systolic blood pressure (SBP) and b diastolic blood pressure (DBP). Black triangles represent women and
grey circles men. Mean value (dotted line) and mean values ± 2 standard deviations (SD) (long dash lines) are depicted as horizontal lines
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sex difference was seen in the supine measurements
were for men there was a decrease in SBP and DBP
between second and third measurement, whereas for
women no significant decrease could be seen based on
the confidence intervals.
Table 2 shows the prevalence of hypertension when
considering different BP measurements for men and
women. As expected, men had higher prevalence of
hypertension irrespective of BP measurement. Consecu-
tive measurements were associated with lower hyperten-
sion rates, as SBP and DBP values diminished with further
measurements. Supine measurements produced lower
hypertension rates. The fact that some participants were
classified as hypertensive in each individual measurement,
but not with the mean of both measurement (see for
example all prevalence estimations for averaged values for
men, which are below individual measurement prevalence
estimates), can be explained with the fact that in one
measurement SBP and in the other DBP determined the
hypertensive status, but after averaging both values, none
of them were above 140/90 mmHg.
Discussion
The present study sought to quantify the variability in
measured BP associated with several factors (arm, position
and repetition) and the consequences of body position
and successive measurements on the estimation of hyper-
tension prevalence. The main findings are that 1) overall,
no mean BP differences were measured according to
arm-side; 2) substantial higher DBP and for men also SBP
a
b
Fig. 2 BP successive measurements differences (measurement 1 vs 2). BP differences first and second sitting measurement (first - second) over
mean of BP first and second sitting measurement for a systolic blood pressure (SBP) and b diastolic blood pressure (DBP). Black triangles represent
women and grey circles men. Mean value (dotted line) and mean values ± 2 standard deviations (SD) (long dash lines) are depicted as horizontal lines
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a c
b d
Fig. 3 Estimated BP by measurement irrespective of arm-side. Values presented from 5th to 8th measurement are the difference between the
mean of one set of right and left measurements and the next set of right and left measurements. Estimated BP with 95%CI and changes in mean
estimated BP across measurements for a systolic blood pressure (SBP) in men; b SBP in women; c diastolic blood pressure (DBP) in men; and d DBP in
women. Δ = difference of the estimated BP measurements; CI = confidence interval
Table 2 Prevalence of hypertension by different BP measurements, sex-stratified
Men Women
Sitting (left arm)
1st measurement 68.7% (N = 664) 55.3% (N = 535)
Mean 1st and 2nd 66.5% (N = 643) Mean 1st and 2nd 51.7% (N = 500)
2nd measurement 66.8% (N = 646) 51.2% (N = 495)
Mean 2nd and 3rd 63.2% (N = 611) Mean 2nd and 3rd 49.4% (N = 478)
3rd measurement 64.0% (N = 619) 50.7% (N = 490)
Supine (arm with higher blood pressure)
1st measurement 57.5% (N = 467) 47.9% (N = 389)
Mean 1st and 2nd 53.9% (N = 438) Mean 1st and 2nd 45.6% (N = 370)
2nd measurement 55.2% (N = 448) 44.2% (N = 359)
Mean 2nd and 3rd 51.2% (N = 416) Mean 2nd and 3rd 42.2% (N = 343)
3rd measurement 51.3% (N = 417) 42.9% (N = 348)
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were measured in sitting than in supine position; 3) there
was a clear BP decline by consecutive measurement and
4) accordingly, the prevalence of hypertension depends
strongly on the body position and successive measure-
ments of BP.
These results replicate previous findings concerning
inter-arm differences. Overall, clinically meaningful
inter-arm differences were not reproducible. Reductions
of 10 mmHg for SBP and 5 mmHg for DBP could be
considered clinically relevant [25]. Yet in approximately
10% of the study-participants the inter-arm difference
for SBP was above 10 mmHg. This difference can be
attributable to random variation but it also could indi-
cate that those subjects suffered from a cardiac disease,
e.g. coarcation of the aorta, upper extremity arterial ob-
struction, dissection or aneurysm of the thoracic aorta
[10, 12, 19, 26], and thus the inter-arm difference could
mask treatment effects. Unfortunately, this hypothesis
cannot be tested, as this accurate diagnostic information
is not available for the study population. Nevertheless, in
a population-based cohort and a patient-based cohort, it
has been shown that there was no association between
short-term blood pressure variability and subclinical
target organ damage [27, 28].
The substantially higher DBP in sitting than in supine
position is in agreement with some previous studies [6, 16].
The finding of higher SBP in sitting than in supine position
however, dissents with those studies [6, 16]. This disagree-
ment could be due to different protocols used in the studies
mentioned above, i.e. same arm-position for measurements
in sitting and supine position could lead to lower differ-
ences among readings. A further influencing factor could
be the measurement order, which in our study was fixed
starting with participants in sitting position. Thus the
position effect cannot be separated from the successive
measurements effect.
The number of readings was shown to have systemat-
ically affected the BP measurement. Compared to previ-
ous studies, we found a smaller decline from first to
second sitting measurement but a more consistent
decline to the third measurement [29]. There were no
further reductions after the third measurement in supine
(almost no difference between third and fourth measure-
ments); thus, it seems that at that point stability was
achieved. There was a similar fall in the estimated preva-
lence of hypertension. This decline occurred regardless
of adjustment for confounders which showed to be re-
lated to the BP decline: baseline BP level, age and BMI
[29]. Analysis with further adjustment for those con-
founders led to almost identical results (data not shown).
The first measurement clearly surpassed following BP
measurements. This fact could be due to a combination
of white coat hypertension, blood pressure variability and/
or device accuracy [30]. Thus, the use of a single
measurement introduces a systematic error that could be
corrected by excluding the first reading. Accordingly, BP
estimates in studies obtained from several readings are
usually lower than those obtained from a single reading
[6, 29, 31]. In the clinical praxis, the uncertainty about the
true BP values has as a consequence fluctuating treatment
decisions [32]. Therefore, guidelines for clinical practice
recommend diagnosing hypertension based on multiple
measurements at different visits. For epidemiological
research, there are several difficulties (i.e. logistic and fi-
nancial) associated with two-visit BP measurements,
which lead to a single visit strategy. On the other hand,
single visit measurements may lead to erroneous conclu-
sions in the interpretation of prevalence rates, awareness,
and medical control of hypertension in different countries
[33–35]. Interestingly, it has been shown that misclassifi-
cation was more common in younger (<30 years) than
older participants [36], with rates varying from 12% in
subjects aged 62 ± 11 years [37], to 35% in subjects aged
39 ± 9 years and 15 to 69 years [36, 38], respectively.
There is evidence that an increased visit-to-visit
variability in SBP is a powerful predictor of end-organ
damage and cognitive decline [39–41]. Moreover,
patients with controlled mean BP but high visit-to-visit
SBP variability had an increased risk of stroke than those
with low SBP variability [42]. Previous studies have
shown visit-to-visit SBP variability to be strongly influ-
enced by drug-class effects with increased variability in
participants medicated with β-blockers [43]. We tried to
replicate these findings with short-term SBP variability,
in stratified models as well as in models with further
adjustment for medication as covariate (Additional file 2:
Table S1) and found no effect of medication use or
medication class (β-blockers or Angiotensin converting
enzyme (ACE) inhibitors) related to SBP or DBP
variability. BP variability results from extrinsic and intrinsic
regulatory mechanisms and substantially differs in clinical
significance and prognostic implications depending on the
time interval considered for its assessment [44].
It has been speculated that the lack of standardization
in BP measurement procedure can lead to clinically
relevant differences in estimations of prevalence and in-
cidence of hypertension [45]. Thus, it is possible that it
also influences the estimates of association studies
between hypertension and other factors. Therefore, pub-
lished prevalence of hypertension should clearly be
accompanied by a definition of the measurement pro-
cedure: arm-side, body position, number of readings and
its combination for the definition of hypertension.
The present study has several important strengths.
Foremost, it is a population-based sample, with well-
defined health outcomes. The results of this study may
be considered representative for the general population
aged 45 to 85 years since a random sample from the
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population registry of the city of Halle had been selected,
and a high participation rate could be achieved. Some
limitations, however, need to be addressed. Due to prac-
ticability reasons, as this study was framed in the exam-
ination part of an epidemiological cohort, there were
some restrictions to BP measurements: 1) there was only
one simultaneous supine measurement; 2) supine
measurements were not consistently throughout on one
arm, but in that with higher BP. This was done following
the recommendation for clinical BP measurement, that
in case of disparity, the arm with higher pressure should
be used for subsequent readings.
Moreover, there might be problems to separate posture
effect from measurement effect. We approached this
problem by including all measurements in a common
statistical model with proper adjustment for measure-
ments within the same subject. However, not all combina-
tions of factors are observed (actually constituting an
incomplete block design) and we have to rely on model
extrapolations for some of the reported differences. Thus
slight differences measured in sitting vs supine positions
(mean difference for SBP was 4.05 mmHg and for DBP
was 2.98 mmHg greater in sitting) could be due to succes-
sive measurements instead of body position.
A further question is how much of the BP variability
can be due to the measuring device. It has been reported
that the OMRON HEM-705CP device fulfils the recom-
mendation criteria of the international protocol [46].
Finally, different resting times were used for sitting and
supine readings (3 and 1 min respectively).
Conclusions
In conclusion, the measured BP strongly depends on
position, successive measurements and combination of
subsequent BP readings. Thus, BP measurements should
only be compared between studies applying equal meas-
urement conditions. Moreover, the first BP measurement
should not be used to define hypertension since it
overestimates mean individual BP. The mean of second
and third measurement offers the advantage of better
reproducibility over single measurements.
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